BlackRock Health Sciences Trust II (BMEZ) Financial Statements
Price: $14.91
Market Cap: $1.51B
Avg Volume: 405.84K
Market Cap: $1.51B
Avg Volume: 405.84K
Country: US
Industry: Asset Management
Sector: Financial Services
Industry: Asset Management
Sector: Financial Services
Overview of Financial Statements
Financial statements are records that provide an overview of a company's financial performance and position. There are three main types of financial statements:
- Income Statement: Shows the company's revenue, expenses, and profit over a specific period.
- Balance Sheet: Provides a snapshot of the company's assets, liabilities, and equity at a specific point in time.
- Cash Flow Statement: Details the cash inflows and outflows from operating, investing, and financing activities over a period.
This page presents both annual and quarterly data for these financial statements. The charts below provide a visual representation of the key metrics from each statement, helping you to quickly understand the financial health of BlackRock Health Sciences Trust II.
Income Statement
| Breakdown | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 |
|---|---|---|---|---|
| Revenue | $- | $- | $- | $- |
| Cost of Revenue | $- | $- | $- | $- |
| Gross Profit | $- | $- | $- | $- |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Research and Development Expenses | $- | $- | $- | $- |
| General and Administrative Expenses | $- | $- | $- | $- |
| Selling and Marketing Expenses | $- | $- | $- | $- |
| Selling General and Administrative Expenses | $- | $- | $- | $- |
| Other Expenses | $- | $- | $- | $- |
| Operating Expenses | $- | $- | $- | $- |
| Cost and Expenses | $- | $- | $- | $- |
| Interest Income | $- | $- | $- | $- |
| Interest Expense | $- | $- | $- | $- |
| Depreciation and Amortization | $228.49K | $236.56K | $206.30K | $171.86K |
| EBITDA | $- | $- | $- | $- |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | $- | $- | $- | $- |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income Expenses Net | $- | $- | $- | $- |
| Income Before Tax | $- | $- | $- | $- |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | $- | $- | $- | $- |
| Net Income | $- | $- | $- | $- |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | $-5.97 | $-2.55 | $11.63 | $1.45 |
| EPS Diluted | $-5.97 | $-2.55 | $11.63 | $1.45 |
| Weighted Average Shares Outstanding | 114.36M | 112.88M | 112.70M | 78.09M |
| Weighted Average Shares Outstanding Diluted | 114.36M | 112.88M | 112.70M | 78.09M |
| SEC Filing | Source | Source | Source | Source |
Balance Sheet
| Breakdown | December 31, 2020 | December 31, 2019 |
|---|---|---|
| Cash and Cash Equivalents | $33.69K | $501.31K |
| Short Term Investments | $- | $- |
| Cash and Short Term Investments | $33.69K | $501.31K |
| Net Receivables | $375.66K | $574.41K |
| Inventory | $- | $- |
| Other Current Assets | $- | $- |
| Total Current Assets | $409.35K | $1.08M |
| Property Plant Equipment Net | $- | $- |
| Goodwill | $- | $- |
| Intangible Assets | $- | $- |
| Goodwill and Intangible Assets | $- | $- |
| Long Term Investments | $3.07B | $1.72B |
| Tax Assets | $- | $- |
| Other Non-Current Assets | $-3.07B | $-1.72B |
| Total Non-Current Assets | $3.07B | $1.72B |
| Other Assets | $19.40M | $8.75M |
| Total Assets | $3.09B | $1.73B |
| Account Payables | $1.76M | $1.52M |
| Short Term Debt | $- | $- |
| Tax Payables | $- | $- |
| Deferred Revenue | $- | $- |
| Other Current Liabilities | $-1.76M | $-1.52M |
| Total Current Liabilities | $1.76M | $1.52M |
| Long Term Debt | $- | $- |
| Deferred Revenue Non-Current | $- | $- |
| Deferred Tax Liabilities Non-Current | $- | $- |
| Other Non-Current Liabilities | $- | $- |
| Total Non-Current Liabilities | $- | $- |
| Other Liabilities | $64.01M | $93.49M |
| Total Liabilities | $64.01M | $93.49M |
| Preferred Stock | $- | $- |
| Common Stock | $1.51B | $1.52B |
| Retained Earnings | $1.52B | $117.28M |
| Accumulated Other Comprehensive Income Loss | $- | $- |
| Other Total Stockholders Equity | $- | $- |
| Total Stockholders Equity | $3.02B | $1.64B |
| Total Equity | $3.02B | $1.64B |
| Total Liabilities and Stockholders Equity | $3.09B | $1.73B |
| Minority Interest | $- | $- |
| Total Liabilities and Total Equity | $3.09B | $1.73B |
| Total Investments | $3.07B | $1.72B |
| Total Debt | $- | $- |
| Net Debt | $-33.69K | $-501.31K |
Cash Flow Statement
| Breakdown | December 31, 2020 | December 31, 2019 |
|---|---|---|
| Net Income | $1.49B | $113.23M |
| Depreciation and Amortization | $- | $- |
| Deferred Income Tax | $- | $- |
| Stock Based Compensation | $- | $- |
| Change in Working Capital | $-66.76M | $70.10M |
| Accounts Receivables | $- | $- |
| Inventory | $- | $- |
| Accounts Payables | $- | $- |
| Other Working Capital | $-66.76M | $- |
| Other Non Cash Items | $-1.31B | $-1.70B |
| Net Cash Provided by Operating Activities | $107.17M | $-1.52B |
| Investments in Property Plant and Equipment | $- | $- |
| Acquisitions Net | $- | $- |
| Purchases of Investments | $- | $- |
| Sales Maturities of Investments | $- | $- |
| Other Investing Activities | $- | $- |
| Net Cash Used for Investing Activities | $- | $- |
| Debt Repayment | $- | $- |
| Common Stock Issued | $- | $- |
| Common Stock Repurchased | $- | $- |
| Dividends Paid | $- | $- |
| Other Financing Activities | $-96.98M | $1.52B |
| Net Cash Used Provided by Financing Activities | $-96.98M | $1.52B |
| Effect of Forex Changes on Cash | $60 | $19 |
| Net Change in Cash | $10.18M | $9.15M |
| Cash at End of Period | $19.44M | $9.25M |
| Cash at Beginning of Period | $9.25M | $100.00K |
| Operating Cash Flow | $107.17M | $-1.52B |
| Capital Expenditure | $- | $- |
| Free Cash Flow | $107.17M | $-1.52B |